Contango Silver & Gold Inc.
For the period ended Dec 31, 2024. Filed Mar 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 17, 2025
CTGO$16.55+6.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash | $20,058,477 | $15,504,819 |
| Restricted cash | 257,045 | 232,572 |
| Prepaid expenses and other | 1,114,522 | 1,112,910 |
| Income taxes receivable | 649,125 | — |
| Total current assets | 22,079,169 | 16,850,301 |
| LONG-TERM ASSETS: | ||
| Investment in Peak Gold, LLC (NOTE 10) | 60,523,622 | 28,064,405 |
| Property & equipment, net | 50,577,097 | 13,326,347 |
| Commitment fee | — | 350,575 |
| Marketable securities | 712,375 | — |
| Total long-term assets | 111,813,094 | 41,741,327 |
| TOTAL ASSETS | $133,892,263 | $58,591,628 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| CURRENT LIABILITIES: | ||
| Accounts payable | $418,836 | $250,739 |
| Accrued liabilities | 2,803,598 | 2,241,087 |
| Advance royalty reimbursement | 855,548 | — |
| Derivative contract liability | 29,076,582 | 2,679,784 |
| Debt, current portion | 42,600,000 | 7,900,000 |
| Total current liabilities | 75,754,564 | 13,071,610 |
| NON-CURRENT LIABILITIES: | ||
| Advance royalty reimbursement | 217,086 | 1,200,000 |
| Asset retirement obligations | 255,769 | 246,227 |
| Contingent consideration liability | 1,100,480 | 1,100,480 |
| Derivative contract liability | 28,615,525 | 20,737,997 |
| Debt non-current portion, net | 26,369,199 | 36,779,859 |
| Deferred tax liability | 306,995 | — |
| Total non-current liabilities | 56,865,054 | 60,064,563 |
| TOTAL LIABILITIES | 132,619,618 | 73,136,173 |
| COMMITMENTS AND CONTINGENCIES (NOTE 12) | ||
| STOCKHOLDERS’ EQUITY (DEFICIT): | ||
| Preferred Stock, 15,000,000 shares authorized | — | — |
| Common Stock, $0.01 par value, 45,000,000 shares authorized; 12,230,959 shares issued and 12,228,479 shares outstanding as of December 31, 2024; 9,454,233 shares issued and 9,451,753 shares outstanding as of December 31, 2023 | 122,308 | 94,542 |
| Additional paid-in capital | 178,270,782 | 124,451,067 |
| Treasury stock at cost (2,480 shares at December 31, 2024, and 2,480 shares at December 31, 2023) | (48,308) | (48,308) |
| Accumulated deficit | (177,072,137) | (139,041,846) |
| STOCKHOLDERS’ EQUITY (DEFICIT) | 1,272,645 | (14,544,545) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $133,892,263 | $58,591,628 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.